Rocuronium Bromide NDC 71288-700

NDC codes

FDA NDC Directory

Product NDC (as listed)71288-700Labeler and product segments. Claims need a package NDC.

Product NDC at billing width71288-0700Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
71288-700-92	71288070092	10 VIAL, MULTI-DOSE in 1 CARTON (71288-700-92) / 5 mL in 1 VIAL, MULTI-DOSE (71288-700-91)Marketed from May 8, 2023

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Rocuronium Bromide
Generic name (nonproprietary): rocuronium bromide
Active ingredients: Rocuronium bromide — 10 mg/mL
Dosage form: Injection
Route: Intravenous
Labeler: Meitheal Pharmaceuticals Inc.
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 213453
Marketing start: May 8, 2023
Listing expires: Dec 31, 2027
Other FDA classes: Neuromuscular Nondepolarizing Blockade (Physiologic effect)
Identifiers: Product ID 71288-700_aad39c88-2e2c-49a6-aa13-de852483661fSPL ID aad39c88-2e2c-49a6-aa13-de852483661fSPL set ID b23aa80e-2af2-4a66-92ed-b1c8863be704RxCUI 1234995UNII I65MW4OFHZ
Pharmacologic class: Nondepolarizing Neuromuscular Blocker

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N471288070092 followed by a unit qualifier and the quantity

Package 71288-0700-92. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jan 9, 2026.

Indications (excerpt from the label)

Rocuronium Bromide Injection is indicated for inpatients and outpatients as an adjunct to general anesthesia to facilitate both rapid sequence and routine tracheal intubation, and to provide skeletal muscle relaxation during surgery or mechanical ventilation. Rocuronium Bromide Injection is a nondepolarizing neuromuscular blocking agent indicated as an adjunct to general anesthesia to facilitate both rapid sequence and routine tracheal intubation, and to provide skeletal muscle relaxation during surgery or mechanical ventilation. ( 1 )

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 213453

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 213453
Product	Strength	Form · route	Labeler	Product NDC
Rocuronium Bromide	Rocuronium bromide 10 mg/mL	InjectionIntravenous	Meitheal Pharmaceuticals Inc.	71288-718
Rocuronium Bromide	Rocuronium bromide 10 mg/mL	InjectionIntravenous	Meitheal Pharmaceuticals Inc.	71288-718